Royalty Pharma Declares $0.235 Fourth-Quarter 2026 Dividend
The dividend is payable Dec. 10, 2026, to holders of record Nov. 13, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Royalty Pharma Declares $0.235 Fourth-Quarter 2026 Dividend
Royalty Pharma’s board approved a $0.235 dividend per Class A ordinary share for the fourth quarter of 2026. Payment is scheduled for December 10, 2026, to shareholders of record at the close of business on a date not specified in the supplied text.
Royalty Pharma declares fourth — quarter dividend of $0.235 per Class A share
Royalty Pharma declared a fourth-quarter 2026 dividend of $0.235 per Class A ordinary share. Payment is due December 10, 2026, to shareholders of record at the close of business on November 13, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PU